Chouquet Anne, Pinto Andrea J, Hennicke Julia, Ling Wai Li, Bally Isabelle, Schwaigerlehner Linda, Thielens Nicole M, Kunert Renate, Reiser Jean-Baptiste
Institut de Biologie Structurale, UMR 5075, Univ. Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
Front Bioeng Biotechnol. 2022 May 24;10:816275. doi: 10.3389/fbioe.2022.816275. eCollection 2022.
Immunoglobulins type-M (IgMs) are one of the first antibody classes mobilized during immune responses against pathogens and tumor cells. Binding to specific target antigens enables the interaction with the C1 complex which strongly activates the classical complement pathway. This biological function is the basis for the huge therapeutic potential of IgMs. But, due to their high oligomeric complexity, production, biochemical characterization, and biophysical characterization are challenging. In this study, we present recombinant production of two IgM models (IgM617 and IgM012) in pentameric and hexameric states and the evaluation of their polymer distribution using different biophysical methods (analytical ultracentrifugation, size exclusion chromatography coupled to multi-angle laser light scattering, mass photometry, and transmission electron microscopy). Each IgM construct is defined by a specific expression and purification pattern with different sample quality. Nevertheless, both purified IgMs were able to activate complement in a C1q-dependent manner. More importantly, BioLayer Interferometry (BLI) was used for characterizing the kinetics of C1q binding to recombinant IgMs. We show that recombinant IgMs possess similar C1q-binding properties as IgMs purified from human plasma.
免疫球蛋白M型(IgMs)是在针对病原体和肿瘤细胞的免疫反应中最早动员的抗体类别之一。与特定靶抗原结合可使其与C1复合物相互作用,从而强烈激活经典补体途径。这种生物学功能是IgMs巨大治疗潜力的基础。但是,由于其高度的寡聚复杂性,其生产、生化表征和生物物理表征都具有挑战性。在本研究中,我们展示了两种IgM模型(IgM617和IgM012)以五聚体和六聚体状态的重组生产,并使用不同的生物物理方法(分析超速离心、尺寸排阻色谱与多角度激光光散射联用、质量光度法和透射电子显微镜)评估它们的聚合物分布。每个IgM构建体都由具有不同样品质量的特定表达和纯化模式定义。尽管如此,两种纯化的IgMs都能够以C1q依赖性方式激活补体。更重要的是,生物层干涉术(BLI)用于表征C1q与重组IgMs结合的动力学。我们表明,重组IgMs具有与从人血浆中纯化的IgMs相似的C1q结合特性。